Site search
Search type

In the news

Healthcare Weekly Review reports DMC, Wayne State help launch major study that could lead to breakthrough in managing "treatment-resistant" hypertension

December 11, 2012

The Detroit Medical Center Cardiovascular Institute and the Wayne State University School of Medicine have begun enrolling patients in a pioneering new study that could lead to a dramatic breakthrough in the battle against treatment-resistant hypertension, a chronic ailment that currently poses a major health threat to more than six million Americans and 100 million people worldwide. The recently launched clinical trial will evaluate the safety and effectiveness of this investigational therapy to treat patients with treatment-resistant hypertension. "This study has a unique design, since patients in the control group may have the option to receive renal denervation treatment six months following randomization, which may help extend the potential benefit of renal denervation to all participants in the trial if the trial demonstrates benefit," said John M. Flack, MD, MPH, professor and Chair of WSU Internal Medicine, as well as the Chief of the Division of Translational Research and Clinical Epidemiology.